Gore this week announced it enrolled the first U.S. patient in its pivotal study for its ViaFort vascular stent. The prospective, non-randomized, multi-center, single-arm study will have a five-year follow-up and will evaluate the investigational Gore ViaFort vascular stent for the treatment of symptomatic iliofemoral venous obstruction. It will … [Read more...] about Gore enrolls first patient in Gore ViaFort vascular stent iliofemoral study
W.L. Gore & Associates
Gore enrolls first U.S. patient in vascular stent trial
W.L. Gore & Associates announced that it enrolled the first U.S. patient in a clinical trial for its Viafort vascular stent. Gore aims to evaluate Viafort for the treatment of symptomatic inferior vena cava (IVC) obstruction with or without iliofemoral obstruction. The prospective, non-randomized, multi-center, single-arm study … [Read more...] about Gore enrolls first U.S. patient in vascular stent trial
Gore voluntarily recalls some balloon catheters
W.L. Gore and Associates recently announced the voluntary product recall of its Molding and Occlusion Balloon (MOB) Catheters. The Newark, Delaware-based manufacturing company issued the warning due to complaints of leakage from the guidewire lumen and the y-hub during the preparation or use of the MOB catheters. The issue could result in … [Read more...] about Gore voluntarily recalls some balloon catheters
W. L. Gore debuts lower-profile endoprosthesis
W.L. Gore this week announced it has launched its lower profile, large diameter Gore ViaBahn Endoprosthesis. The device design reduces the delivery profile for larger 9-13 mm diameter stent grafts by up to 3 Fr to enable delivery through smaller sheaths. The smaller introducer sheaths result in a lower risk of vascular access complications and … [Read more...] about W. L. Gore debuts lower-profile endoprosthesis
W.L. Gore officials think they can spur insulin delivery system innovation
W.L. Gore announced this week that it is investing in PhysioLogic Devices, a startup developing an implantable intraperitoneal insulin delivery system. The size of the investment was not disclosed. But it was part of Gore's Micro-Equity Investment (MEI) program, which provides investments of up to $500,000. W.L. Gore officials think the … [Read more...] about W.L. Gore officials think they can spur insulin delivery system innovation
